Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |